LANXESS Aktiengesellschaft

OTCPK:LNXS.F Stock Report

Market Cap: US$1.7b

LANXESS Valuation

Is LNXS.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LNXS.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LNXS.F ($20.16) is trading above our estimate of fair value ($16.75)

Significantly Below Fair Value: LNXS.F is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LNXS.F?

Key metric: As LNXS.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for LNXS.F. This is calculated by dividing LNXS.F's market cap by their current revenue.
What is LNXS.F's PS Ratio?
PS Ratio0.3x
Sales€5.89b
Market Cap€1.47b

Price to Sales Ratio vs Peers

How does LNXS.F's PS Ratio compare to its peers?

The above table shows the PS ratio for LNXS.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.5x
HUN Huntsman
0.3x3.11%US$1.8b
CC Chemours
0.3x3.95%US$1.8b
LXU LSB Industries
1x1.08%US$612.2m
FMC FMC
0.5x4.18%US$1.7b
LNXS.F LANXESS
0.3x1.51%US$1.5b

Price-To-Sales vs Peers: LNXS.F is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.5x).

Price to Sales Ratio vs Industry

How does LNXS.F's PS Ratio compare vs other companies in the US Chemicals Industry?

23 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.1.1x4.2%
LNXS.F LANXESS
 0.3x1.51%US$1.74b
TROX Tronox Holdings
0.2x3.53%US$680.19m
KOP Koppers Holdings
0.3x0.73%US$528.60m
LNXS.F 0.3xIndustry Avg. 1.1xNo. of Companies22PS01.22.43.64.86+
23 CompaniesEstimated GrowthMarket Cap
Industry Avg.1.1x23.0%
LNXS.F LANXESS
 0.3x39.13%US$1.74b
No more companies

Price-To-Sales vs Industry: LNXS.F is good value based on its Price-To-Sales Ratio (0.3x) compared to the US Chemicals industry average (1.2x).

Price to Sales Ratio vs Fair Ratio

What is LNXS.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LNXS.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate LNXS.F's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LNXS.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$20.16
US$22.66
+12.40%
32.26%US$39.85US$11.72n/a15
Dec ’26US$19.00
US$23.41
+23.19%
30.18%US$39.20US$11.53n/a15
Nov ’26n/a
US$28.30
0%
23.25%US$43.80US$19.60n/a15
Oct ’26US$25.16
US$30.27
+20.33%
21.83%US$44.59US$19.95n/a15
Sep ’26n/a
US$30.88
0%
19.95%US$44.45US$19.89n/a15
Aug ’26US$27.75
US$31.78
+14.52%
18.93%US$44.07US$23.20n/a15
Jul ’26US$30.30
US$32.83
+8.34%
21.17%US$47.16US$23.58n/a16
Jun ’26US$31.00
US$31.68
+2.18%
21.36%US$45.41US$21.91n/a17
May ’26n/a
US$32.43
0%
22.77%US$46.70US$22.21n/a17
Apr ’26US$30.80
US$32.69
+6.14%
20.08%US$44.23US$21.58n/a15
Mar ’26n/a
US$29.75
0%
18.57%US$38.37US$20.74n/a16
Feb ’26US$27.85
US$29.89
+7.32%
18.33%US$38.81US$20.98n/a16
Jan ’26US$24.43
US$30.47
+24.76%
19.51%US$40.15US$21.13n/a16
Dec ’25n/a
US$30.47
0%
19.51%US$40.15US$21.13US$19.0016
Nov ’25US$28.90
US$33.14
+14.68%
20.16%US$45.68US$22.84n/a17
Oct ’25n/a
US$32.41
0%
19.90%US$46.90US$23.45US$25.1618
Sep ’25US$28.00
US$30.96
+10.56%
19.98%US$46.30US$23.15n/a18
Aug ’25US$24.50
US$30.99
+26.50%
19.24%US$45.76US$22.88US$27.7518
Jul ’25n/a
US$30.43
0%
18.53%US$45.10US$22.55US$30.3019
Jun ’25n/a
US$31.17
0%
17.97%US$45.59US$22.80US$31.0019
May ’25n/a
US$30.11
0%
17.41%US$44.93US$22.46n/a19
Apr ’25US$27.30
US$30.21
+10.63%
18.58%US$45.11US$22.56US$30.8019
Mar ’25US$25.16
US$30.83
+22.54%
18.93%US$45.17US$22.59n/a18
Feb ’25US$27.97
US$31.12
+11.26%
18.93%US$45.59US$22.80US$27.8518
Jan ’25US$31.00
US$31.75
+2.42%
20.13%US$45.85US$22.93US$24.4318
Dec ’24US$24.30
US$34.70
+42.81%
31.55%US$70.90US$22.91n/a19
US$22.82
Fair Value
11.7% undervalued intrinsic discount
15
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/28 01:48
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LANXESS Aktiengesellschaft is covered by 37 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James KnightBarclays
Anil ShenoyBarclays
Andres Castanos-MollorBerenberg